New US FDA-funded study aims to alleviate generic Prograf-switching concerns

The US FDA is to fund a new study at the University of Cincinnati (UC) aimed at ending questions over generic versus brand, and generic versus generic, for tacrolimus – an immunosuppressive drug for transplant patients.